Enveric Biosciences Inc (ENVB)

Currency in USD
1.960
-0.050(-2.49%)
Closed·
1.9600.000(0.00%)
·

Enveric Biosciences Inc Company Profile

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.

Contact Information

Address
245 First Street Riverview II 18 th Floor, Cambridge, 02142, United States

Top Executives

Name
Title
Since
Age
Michael D. WebbIndependent Chairman of the Board202267
Joseph Edward TuckerCEO & Director202157
George A. KeglerIndependent Non-Employee Director202070
Maurizio FavaChairman of Scientific Advisory Board2022-
Frank PasqualoneIndependent Director202270
Marcus SchabackerIndependent Non-Employee Director202062
Stephen M. StahlMember of Scientific Advisory Board2022-
Sheila DeWittIndependent Director202465
John H. KrystalMember of Scientific Advisory Board2022-
Michael B. LiebowitzMember of Scientific Advisory Board2022-
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.